AcelRx Pharmaceuticals In...

NASDAQ: ACRX · Real-Time Price · USD
0.86
0.06 (7.50%)
At close: Jan 09, 2024, 10:00 PM

AcelRx Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.15 -1.02 0.35 -1.91
PEG Ratio
-0.00 0.01 -0.00 0.05
PS Ratio
n/a 16.10 9.42 23.82
PB Ratio
1.86 0.74 0.77 -1.87
P/FCF Ratio
-1.17 -0.6 -0.58 -2.11
P/OCF Ratio
-1.17 -0.6 -0.59 -2.24
OCF/S Ratio
n/a -26.87 -16 -10.65
Debt / Equity Ratio
n/a n/a 0.38 -0.52
Quick Ratio
3.56 2.56 1.70 2.94
Current Ratio
3.56 2.56 1.78 3.00
Asset Turnover
n/a 0.03 0.04 0.04
Interest Coverage
38.71 -126.04 -18.24 -15.7
Return on Equity
-1.63 -0.73 2.19 0.98
Return on Assets
-0.71 -0.5 1.01 -0.45
Return on Invested Capital
-0.98 -1.06 -0.49 -0.52
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a 1.00 -0.46 -0.33
Net Profit Margin
n/a -15.8 26.96 -12.46
Pretax Profit Margin
n/a -15.8 33.39 -12.45
Operating Profit Margin
n/a -25.94 -11.49 -12.76
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -15.12 -9.71 -10.94